Teicoplanin-Evultis 200 mg
Teicoplanin-Evultis 200 mg is a medicine authorised by Swissmedic under authorisation number 69777. The authorisation holder is Evultis SA. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 03 April 2025 and the authorisation is limited until 02 April 2030. ATC code J01XA02 places the medicine in the group Antibacterials for systemic use.
| Authorisation number | 69777 |
|---|---|
| Name | Teicoplanin-Evultis 200 mg |
| Full name | Teicoplanin-Evultis 200 mg, Polvere per soluzione iniettabile/per infusione o soluzione orale |
| Authorisation holder | Evultis SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | J01XA02 |
| First authorisation | 03 April 2025 |
| Authorisation validity | 02 April 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Teicoplanin-Evultis 200 mg, Polvere per soluzione iniettabile/per infusione o soluzione orale | A | 03 April 2025 |
| 2 | Teicoplanin-Evultis 400 mg, Polvere per soluzione iniettabile/per infusione o soluzione orale | A | 03 April 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 5 | Durchstechflasche(n) | J01XA02 | 08.01.9. | A |
| 2 | 10 | Durchstechflasche(n) | J01XA02 | 08.01.9. | A |
| 3 | 5 | Durchstechflasche(n) | J01XA02 | 08.01.9. | A |
| 4 | 10 | Durchstechflasche(n) | J01XA02 | 08.01.9. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Teicoplanin-Evultis 200 mg authorised in Switzerland?
Yes. Teicoplanin-Evultis 200 mg is authorised by Swissmedic under authorisation number 69777, data as of 01 September 2026. The authorisation is limited until 02 April 2030.
Which dispensing category does Teicoplanin-Evultis 200 mg have?
Teicoplanin-Evultis 200 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Teicoplanin-Evultis 200 mg?
The authorisation holder is Evultis SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.